top of page

Weekly Drug News : January 16, 2019

The resurgence of whooping cough is an ongoing concern in the U.S., and this week the FDA cleared Adacel as first Tdap vaccine for repeat vaccination. Plus, Cabometyx gains a new use in aggressive liver cancer. Researchers at Georgia Tech are using microneedle techniques to develop birth control, and a reality check on cervical cancer screening is posted. Finally, first-time generics, like Teva’s newly approved seizure drug vigabatrin, are a top FDA priority.


Recent Posts

See All


Rated 0 out of 5 stars.
No ratings yet

Add a rating
bottom of page